The Future of Data in Pharma: Data Privacy, Data Ownership and Going Beyond the Pill

Posted by ZS Editors on Wed, Feb 12, 2020

Remember when big data was big news? Now all we hear about is AI, but that hasn’t made data any less relevant. Data is the fuel that feeds the business and the future of pharma, let alone AI. The world is becoming more and more data dependent while slow, tectonic shifts are under way across healthcare: There’s an increasing focus on the value of medical care over volume. The patient experience is becoming a higher priority. Data privacy and data ownership concerns are constantly threatening to upend the status quo with regulations that could be hugely disruptive.


>
Read More

The Evolving Data Landscape Will Transform Healthcare. Here Are Four Trends to Watch.

Posted by Paul Darling on Fri, Jun 28, 2019

Oladele Ojo co-wrote this blog post with Paul Darling. 

The healthcare system generates approximately a zettabyte (a trillion gigabytes) of data each year, which includes both classic data from sources such as EHRs, diagnostics and genetics, as well as newer data sources such as gut biome sensors, wearable devices and environmental monitors, and social media. Consequently, it’s now possible to quantify a person across three dimensions of human existence: biological, environmental and digital/social.


>
Read More

How Pharma Can Thrive in an Analytics-Enabled Healthcare World

Posted by Dharmendra Sahay on Mon, Dec 11, 2017

Rohan Fernando co-wrote this blog post with Dharmendra Sahay.

Through data and analytics, healthcare is on the verge of a transformation, one that will change the way that providers, payers and pharmaceutical manufacturers help people manage wellness. The various players in today’s healthcare ecosystem are racing time—and each other—to collect and control patient information, all in the name of making quicker, more effective decisions and optimizing outcomes.


>
Read More

The Death of the Data Warehouse

Posted by ZS Editors on Thu, Sep 28, 2017

Traditional data warehouses have limited utility in today’s healthcare ecosystem because they often can’t process the types of unstructured data that give pharmaceutical organizations a competitive edge. Rigid data storage systems and old-school modeling no longer cut it. Pharmaceutical firms need a modern data infrastructure that’s capable of handling structured and unstructured data, sufficiently scalable and technologically able to support advanced analytics, resulting in actionable insights that can enable commercial teams to make data-driven decisions in real time. 


>
Read More

Data Analytics Give Oncology Products Competitive Edge

Posted by Maria Whitman on Tue, Mar 24, 2015

Recent launches have proven that having a great product isn’t enough. To succeed in the oncology market, pharmaceutical and biotech companies must be able to understand performance and opportunities, and explain the difference for increasingly specific patient populations. Data has come a long way, and integrated data analytics is a powerful way to surface and interpret an oncology product’s opportunity amid brutal competition.


>
Read More